Anesthesia and analgesia · 2025
Isoflurane Exposure Influence on Sleep Architecture in a Rat Model of Alzheimer's Disease.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Kreuzer Matthias, Keating Glenda L, Sinon Christopher G, Fenzl Thomas, Schneider Gerhard, Rye David B, García Paul S
Аннотация
BACKGROUND: A clear understanding of how general anesthesia affects the brain in patients with Alzheimer disease will be crucial to optimize clinical care. We present results from laboratory investigations with a rat model used to study Alzheimer disease (TgF344-AD) to evaluate the effect of isoflurane anesthesia on the early recovery from anesthesia and postanesthesia sleep architecture in animals that exhibit mild symptoms of cognitive decline.
METHODS: We used electroencephalogram (EEG) and electromyogram recordings to distinguish WAKE, NREM, and REM sleep in 8 rats from the transgenic model (AD) group and 7 age-matched control (AC) rats, 17 to 18 months of age. We evaluated the sleep architecture before and after a 1-hour exposure to 1.5% isoflurane. Therefore, we investigated the 12-hour active (lights-off) baseline period before anesthesia and the 5-hour recovery period after anesthesia emergence, and the following 12-hour lights-off period.
RESULTS: The transgenic rats took longer to ambulate after the isoflurane challenge (mean [range] 1256 seconds [838-1565 seconds] vs 799 seconds [530-1125 seconds]; P = .038). There was no significant difference in the proportion of vigilance states during the 5-hour recovery period (ANOVA: WAKE, P = .081; NREM, P = .082; and REM, P = .993). In the first active period after isoflurane, the age-matched control rats showed increased sleep in the first active period after anesthesia compared to WAKE (ANOVA: P < .001), while the transgenic rats showed a higher overall WAKE duration (ANOVA: P < .001) and a more fragmented sleep behavior.
CONCLUSIONS: Isoflurane affected the sleep architecture in the transgenic model for studying Alzheimer disease. The prolonged time to ambulation, the more fragmented SLEEP/WAKE behavior, and the relative hyperactivity compared to age-matched control rats may imply that Alzheimer disease diminishes the brain's dynamic range to adapt to altered levels of consciousness.
METHODS: We used electroencephalogram (EEG) and electromyogram recordings to distinguish WAKE, NREM, and REM sleep in 8 rats from the transgenic model (AD) group and 7 age-matched control (AC) rats, 17 to 18 months of age. We evaluated the sleep architecture before and after a 1-hour exposure to 1.5% isoflurane. Therefore, we investigated the 12-hour active (lights-off) baseline period before anesthesia and the 5-hour recovery period after anesthesia emergence, and the following 12-hour lights-off period.
RESULTS: The transgenic rats took longer to ambulate after the isoflurane challenge (mean [range] 1256 seconds [838-1565 seconds] vs 799 seconds [530-1125 seconds]; P = .038). There was no significant difference in the proportion of vigilance states during the 5-hour recovery period (ANOVA: WAKE, P = .081; NREM, P = .082; and REM, P = .993). In the first active period after isoflurane, the age-matched control rats showed increased sleep in the first active period after anesthesia compared to WAKE (ANOVA: P < .001), while the transgenic rats showed a higher overall WAKE duration (ANOVA: P < .001) and a more fragmented sleep behavior.
CONCLUSIONS: Isoflurane affected the sleep architecture in the transgenic model for studying Alzheimer disease. The prolonged time to ambulation, the more fragmented SLEEP/WAKE behavior, and the relative hyperactivity compared to age-matched control rats may imply that Alzheimer disease diminishes the brain's dynamic range to adapt to altered levels of consciousness.